1,308
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis

, , , , , & show all
Pages 237-246 | Received 01 Aug 2016, Accepted 13 Sep 2016, Published online: 05 Oct 2016

References

  • Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
  • Meza-Junco J, Montano-Loza AJ, Liu DM, et al. (2012). Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how? Cancer Treat Rev 38:54–62.
  • Ryder SD. (2003). Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52:1–8.
  • European Association For The Study Of The Liver, European Organisationi For Research And Treatment Of Cancer. (2012). EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–43.
  • Omata M, Lesmana LA, Tateishi R, et al. (2010). Asian Pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–74.
  • McClune AC, Tong MJ. (2010). Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis 14:461–76.
  • Ansari D, Andersson R. (2012). Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumours. World J Gastroenterol 18:1003–8.
  • Bruix J, Sherman M. (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
  • Forner A, Bruix J. (2010). Ablation for hepatocellular carcinoma: is there need to have a winning technique? J Hepatol 52:310–2.
  • Gervais DA, Arellano RS. (2011). Percutaneous tumor ablation for hepatocellular carcinoma. AJR Am J Roentgenol 197:789–94.
  • Lencioni R. (2010). Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–73.
  • Lau WY, Lai EC. (2009). The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249:20–5.
  • Cho YK, Kim JK, Kim MY, et al. (2009). Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–9.
  • Germani G, Pleguezuelo M, Gurusamy K, et al. (2010). Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol 52:380–8.
  • Orlando A, Leandro G, Olivo M, et al. (2009). Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomised controlled trials. Am J Gastroenterol 104:514–24.
  • Bouza C, Lopez-Cuadrado T, Alcazar R, et al. (2009). Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 9:31.
  • Shen A, Zhang H, Tang C, et al. (2013). Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. J Gastroenterol Hepatol 28:793–800.
  • Higgins JPT, Green S (eds). (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, Available from www.cochrane-handbook.org
  • Lin ZZ, Shau WY, Hsu C, et al. (2013). Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumour size. PLoS One 8:e80276.
  • Livraghi T, Goldberg SN, Lazzaroni S, et al. (1999). Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–61.
  • Lencioni RA, Allgaier HP, Cioni D, et al. (2003). Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–40.
  • Lin SM, Lin CJ, Lin CC, et al. (2004). Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127:1714–23.
  • Lin SM, Lin CJ, Lin CC, et al. (2005). Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–6.
  • Shiina S, Teratani T, Obi S, et al. (2005). A randomised controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–30.
  • Brunello F, Veltri A, Carucci P, et al. (2008). Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomised controlled trial. Scand J Gastroenterol 43:727–35.
  • Giorgio A, Di Sarno A, De Stefano G, et al. (2011). Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomised controlled trial. Anticancer Res 31:2291–5.
  • Azab M, Zaki S, El-Shetey AG, et al. (2011). Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma. Arab J Gastroenterol 12:113–18.
  • Shankar S, vanSonnenberg E, Morrison PR, et al. (2004). Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation. AJR Am J Roentgenol 183:1425–9.
  • Kurokohchi K, Watanabe S, Masaki T, et al. (2005). Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol 11:1426–32.
  • Zhang YJ, Liang HH, Chen MS, et al. (2007). Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 244:599–607.
  • Wong SN, Lin CJ, Lin CC, et al. (2008). Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol 190:W187–95.
  • Cha DI, Lee MW, Rhim H, et al. (2013). Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations. Korean J Radiol 14:240–7.
  • Goldberg SN. (2001). Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 13:129–47.
  • Mulier S, Jiang Y, Jamart J, et al. (2015). Bipolar radiofrequency ablation with 2 x 2 electrodes as a building block for matrix radiofrequency ablation: Ex vivo liver experiments and finite element method modelling. Int J Hyperthermia 31:649–65.
  • Shiina S, Tateishi R, Yoshida H, et al. (2007). Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation. Saudi Med J 28:831–7.
  • Lee DH, Lee JM, Lee JY, et al. (2014). Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–9.
  • Park EK, Kim HJ, Kim CY, et al. (2014). A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Ann Surg Treat Res 87:72–80.
  • Lee YH, Hsu CY, Chu CW, et al. (2015). Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses. J Clin Gastroenterol 49:242–9.
  • Fang Y, Chen W, Liang X, et al. (2014). Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. J Gastroenterol Hepatol 29:193–200.
  • Hocquelet A, Balageas P, Laurent C, et al. (2015). Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: a study of 281 Western patients. Int J Hyperthermia 31:749–57.
  • Weis S, Franke A, Mossner J, et al. (2013). Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev 12:11–54.
  • de Baere T, Risse O, Kuoch V, et al. (2003). Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181:695–700.
  • Seror O, N'Kontchou G, Tin Tin Htar M, et al. (2006). Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost. Gastroenterol Clin Biol 30:1265–73.
  • Nakai M, Sato M, Yamada K, et al. (2001). [Percutaneous hot ethanol injection therapy (PHEIT) for hepatocellular carcinoma]. Gan to Kagaku Ryoho 28:1633–7.
  • Goldberg SN, Kruskal JB, Oliver BS, et al. (2000). Percutaneous tumour ablation: increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumour model. Radiology 217:827–31.
  • Hall SK, Ooi EH, Payne SJ. (2015). Cell death, perfusion and electrical parameters are critical in models of hepatic radiofrequency ablation. Int J Hyperthermia 31:538–50.
  • Poch FG, Rieder C, Ballhausen H, et al. (2016). The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo. Int J Hyperthermia 32:749–56.
  • Kurokohchi K, Watanabe S, Masaki T, et al. (2002). Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma. Int J Oncol 21:841–6.
  • Kurokohchi K, Watanabe S, Masaki T, et al. (2002). Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Int J Oncol 21:611–5.
  • Jiang K, Dong J, Zhang W, et al. (2014). Effect of one-off complete tumour radiofrequency ablation on liver function and postoperative complication in small hepatocellular carcinoma. Eur J Surg Oncol 40:576–83.
  • Seror O, N'Kontchou G, Muhammad M, et al. (2007). [The impact of large vessel proximity on effectiveness of radiofrequency ablation of hepatocellular carcinoma: a controlled study]. J Radiol 88:1157–64.
  • Teratani T, Yoshida H, Shiina S, et al. (2006). Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101–8.
  • Sakr AA, Saleh AA, Moeaty AA. (2005). The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma. Eur J Radiol 54:418–25.
  • Huang GL, Lin MX, Xie XY, et al. (2014). Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma. Eur Radiol 24:1565–71.
  • Lin JW, Lin CC, Chen WT, Lin SM. (2014). Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1–4 cm) and in high-risk locations. Kaohsiung J Med Sci 30:396–401.
  • Huang H, Liang P, Yu XL, et al. (2015). Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia 31:40–7.
  • Vallone P, Catalano O, Izzo F, Siani A. (2006). Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 29:544–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.